Hotline 24/7: 0909384389

Share links:

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Ngày 18/02/2022 03:24 | Lượt xem: 603

Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled trial (RCT), evaluating the Dynamx coronary bioadaptor system, a drug-eluting coronary artery implant that adapts to vessel physiology, allowing for the restoration of normal vessel functions.

The BIOADAPTOR RCT is a multicentre, randomised, single-blind study enrolling 444 patients from 35 centres in Japan, Europe and New Zealand treated with the Dynamx Bioadaptor in a 1:1 randomisation to the Resolute Onyx drug-eluting stent (Medtronic). The primary endpoint of the study is target lesion failure (TLF) at one year. Secondary endpoints include measures of the implant’s ability to accommodate vessel growth from disease progression and restore vessel pulsatility in an imaging subset, as well as the incidence of major cardiovascular events.

“The bioadaptor is a revolutionary innovation in percutaneous coronary intervention and we are enthusiastic about studying the device’s ability to accommodate and restore vessel movement and function,” said Shigeru Saito, director of the Cardiology and Catheterization Laboratory at Shonan Kamakuru General Hospital, Kanagawa, Japan, and principal investigator of the BIOADAPTOR RCT. “Despite the challenges presented by the COVID-19 pandemic, we are proud that we were able to enrol the trial in about one year.”

According to Elixir Medical, the device incorporates “uncaging elements” in its metallic implant design, allowing for the restoration of natural artery function and movement essential to cardiovascular performance. The Dynamx Bioadaptor is designed to improve clinical outcomes by adapting to vessel physiology and restoring positive adaptive remodelling, pulsatility and rotation, the company adds.

Source cardiovascularNews

Duc Tin clinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support